Page last updated: 2024-08-24

pyrazolo(3,4-d)pyrimidine and Cancer of the Thyroid

pyrazolo(3,4-d)pyrimidine has been researched along with Cancer of the Thyroid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alì, G; Antonelli, A; Berti, P; Bocci, G; Corti, A; Da Settimo, F; Danesi, R; Fallahi, P; Ferrari, SM; Fioravanti, A; Fontanini, G; La Motta, C; Miccoli, P; Minuto, M; Piaggi, S; Sartini, S1

Other Studies

1 other study(ies) available for pyrazolo(3,4-d)pyrimidine and Cancer of the Thyroid

ArticleYear
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer.
    The Journal of clinical endocrinology and metabolism, 2011, Volume: 96, Issue:2

    Topics: Animals; Annexin A5; Antineoplastic Agents; Apoptosis; Capillaries; Carcinoma, Papillary; Cell Count; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; DNA, Neoplasm; Humans; Male; Mice; Mice, Nude; Microdissection; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins B-raf; Pyrazoles; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Structure-Activity Relationship; Thrombospondins; Thyroid Neoplasms; Xenograft Model Antitumor Assays

2011